FUSN [NASD]
Fusion Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.75 Insider Own0.70% Shs Outstand43.36M Perf Week-5.94%
Market Cap83.55M Forward P/E- EPS next Y-2.10 Insider Trans-37.37% Shs Float34.24M Perf Month-13.81%
Income-75.60M PEG- EPS next Q-0.52 Inst Own65.50% Short Float0.07% Perf Quarter-46.07%
Sales2.10M P/S39.79 EPS this Y47.40% Inst Trans-0.01% Short Ratio0.71 Perf Half Y-75.21%
Book/sh4.59 P/B0.45 EPS next Y-9.40% ROA-30.70% Target Price16.25 Perf Year-74.79%
Cash/sh4.89 P/C0.42 EPS next 5Y- ROE-33.90% 52W Range1.99 - 9.50 Perf YTD-50.60%
Dividend- P/FCF- EPS past 5Y- ROI-35.40% 52W High-78.32% Beta-
Dividend %- Quick Ratio17.90 Sales past 5Y- Gross Margin- 52W Low3.52% ATR0.14
Employees86 Current Ratio17.90 Sales Q/Q20.00% Oper. Margin- RSI (14)29.77 Volatility7.11% 6.09%
OptionableYes Debt/Eq0.05 EPS Q/Q30.40% Profit Margin- Rel Volume3.20 Prev Close2.14
ShortableYes LT Debt/Eq0.05 EarningsAug 09 BMO Payout- Avg Volume36.23K Price2.06
Recom1.50 SMA20-10.25% SMA50-24.12% SMA200-61.64% Volume115,827 Change-3.74%
Jul-06-22Initiated William Blair Outperform
Oct-19-21Resumed Morgan Stanley Overweight $19
Aug-26-21Initiated B. Riley Securities Buy $17
Jul-21-20Initiated Wedbush Outperform $25
Jul-21-20Initiated Jefferies Buy $25
Jul-21-20Initiated Cowen Outperform
Aug-13-22 08:09AM  
Aug-12-22 09:35AM  
Aug-09-22 08:25AM  
07:00AM  
Aug-03-22 10:00AM  
Aug-02-22 04:45PM  
10:00AM  
Jul-29-22 06:24AM  
Jul-07-22 07:55AM  
07:55AM  
Jun-30-22 09:02AM  
Jun-23-22 07:45AM  
07:45AM  
Jun-14-22 04:25PM  
04:25PM  
Jun-10-22 07:42AM  
Jun-09-22 08:09AM  
07:00AM  
Jun-08-22 04:35PM  
Jun-06-22 04:35PM  
04:35PM  
May-20-22 11:08AM  
May-11-22 04:45PM  
04:45PM  
May-10-22 07:00AM  
May-04-22 04:40PM  
04:40PM  
Apr-26-22 04:40PM  
Apr-20-22 10:33AM  
Mar-30-22 04:35PM  
04:35PM  
Mar-24-22 07:45AM  
07:45AM  
Mar-17-22 07:00AM  
Mar-09-22 04:05PM  
04:05PM  
Feb-28-22 04:15PM  
04:15PM  
Feb-19-22 07:29AM  
Feb-09-22 08:35AM  
08:35AM  
Jan-21-22 08:30AM  
Jan-18-22 04:30PM  
Jan-11-22 08:16AM  
08:16AM  
08:15AM  
08:15AM  
Jan-10-22 04:30PM  
04:30PM  
Dec-08-21 07:38PM  
Nov-11-21 04:15PM  
04:15PM  
Nov-09-21 07:30AM  
Nov-03-21 04:30PM  
Nov-02-21 04:15PM  
04:15PM  
Oct-20-21 04:05PM  
04:05PM  
Sep-28-21 04:05PM  
04:05PM  
Sep-23-21 04:10PM  
Sep-21-21 08:35AM  
08:35AM  
Sep-02-21 04:10PM  
Aug-31-21 04:30PM  
Aug-23-21 07:47AM  
Aug-12-21 04:05PM  
04:05PM  
Aug-10-21 07:30AM  
07:30AM  
Aug-05-21 04:05PM  
04:05PM  
Jul-28-21 04:15PM  
04:15PM  
Jul-07-21 08:00AM  
08:00AM  
Jun-14-21 04:10PM  
04:10PM  
Jun-07-21 04:10PM  
04:10PM  
Jun-02-21 08:30AM  
08:30AM  
May-27-21 04:05PM  
May-25-21 03:08AM  
May-11-21 07:30AM  
07:30AM  
May-06-21 10:46AM  
08:20AM  
08:20AM  
Apr-14-21 08:45AM  
08:45AM  
Apr-10-21 08:35AM  
Apr-01-21 04:15PM  
04:15PM  
08:00AM  
08:00AM  
Mar-26-21 03:51AM  
Mar-25-21 07:30AM  
07:30AM  
Mar-02-21 07:30AM  
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GANNON STEVENDirectorAug 11Buy2.0344,40090,13256,400Aug 11 04:19 PM
Valliant JohnChief Executive OfficerApr 27Sale6.034,51127,201318,147Apr 27 04:34 PM
Valliant JohnChief Executive OfficerApr 26Sale6.072,14713,032322,658Apr 27 04:34 PM
Valliant JohnChief Executive OfficerApr 25Sale6.032,03612,277324,805Apr 27 04:34 PM
Valliant JohnChief Executive OfficerApr 21Sale6.019225,541326,841Apr 22 08:04 PM
Valliant JohnChief Executive OfficerApr 20Sale6.023672,209327,763Apr 22 08:04 PM
Valliant JohnChief Executive OfficerApr 13Sale6.4111,99476,882328,130Apr 13 06:10 PM
Valliant JohnChief Executive OfficerApr 12Sale7.1018,255129,610340,124Apr 13 06:10 PM
Valliant JohnChief Executive OfficerApr 11Sale7.372,60019,162358,379Apr 13 06:10 PM
Valliant JohnChief Executive OfficerApr 08Sale7.528266,212360,979Apr 08 04:21 PM
Valliant JohnChief Executive OfficerApr 07Sale7.561,2559,488361,805Apr 08 04:21 PM
Valliant JohnChief Executive OfficerApr 06Sale7.58100758363,060Apr 08 04:21 PM
Valliant JohnChief Executive OfficerApr 05Sale7.672,10016,107363,160Apr 05 05:01 PM
Valliant JohnChief Executive OfficerApr 04Sale7.817005,467365,260Apr 05 05:01 PM
Valliant JohnChief Executive OfficerApr 01Sale7.751,0007,750365,960Apr 05 05:01 PM
Valliant JohnChief Executive OfficerMar 30Sale7.523002,256366,960Apr 01 05:36 PM
Valliant JohnChief Executive OfficerMar 29Sale7.522001,504367,260Mar 29 04:29 PM
Valliant JohnChief Executive OfficerMar 28Sale7.559,60072,480367,460Mar 29 04:29 PM
Valliant JohnChief Executive OfficerMar 25Sale7.425003,710377,060Mar 29 04:29 PM
Valliant JohnChief Executive OfficerMar 23Sale7.50100750378,260Mar 24 05:32 PM
Valliant JohnChief Executive OfficerMar 22Sale7.534,00030,120378,360Mar 24 05:32 PM
Valliant JohnChief Executive OfficerMar 21Sale7.467005,222377,560Mar 24 05:32 PM
Valliant JohnChief Executive OfficerMar 21Sale7.471,50011,205382,360Mar 21 05:47 PM
Valliant JohnChief Executive OfficerMar 18Sale7.611,2049,162383,860Mar 21 05:47 PM
Valliant JohnChief Executive OfficerMar 17Sale7.519006,759385,064Mar 21 05:47 PM
Valliant JohnChief Executive OfficerMar 16Sale6.99100699385,964Mar 16 04:29 PM
Valliant JohnChief Executive OfficerMar 15Sale7.12100712386,064Mar 16 04:29 PM
Valliant JohnChief Executive OfficerMar 14Sale6.961,3009,048386,164Mar 16 04:29 PM
Valliant JohnChief Executive OfficerMar 11Sale7.13100713387,464Mar 14 04:18 PM
Valliant JohnChief Executive OfficerMar 10Sale7.061,90013,414387,564Mar 14 04:18 PM
Valliant JohnChief Executive OfficerMar 09Sale6.948225,705389,464Mar 14 04:18 PM
Valliant JohnChief Executive OfficerMar 08Sale6.923,00420,788390,286Mar 08 04:59 PM
Valliant JohnChief Executive OfficerMar 07Sale6.993,10021,669393,290Mar 08 04:59 PM
Valliant JohnChief Executive OfficerMar 04Sale7.328,40061,488396,390Mar 08 04:59 PM
Valliant JohnChief Executive OfficerMar 03Sale7.282001,456404,790Mar 03 04:53 PM
Valliant JohnChief Executive OfficerMar 02Sale7.4426,546197,502404,990Mar 03 04:53 PM
Valliant JohnChief Executive OfficerMar 01Sale7.378476,242431,536Mar 03 04:53 PM
Valliant JohnChief Executive OfficerFeb 28Sale7.403,10022,940432,383Feb 28 07:13 PM
Valliant JohnChief Executive OfficerFeb 25Sale7.578,15261,711435,483Feb 28 07:13 PM
Valliant JohnChief Executive OfficerFeb 24Sale7.412,50018,525443,635Feb 28 07:13 PM
Valliant JohnChief Executive OfficerFeb 23Sale7.7729,299227,653446,135Feb 23 05:58 PM
Valliant JohnChief Executive OfficerFeb 22Sale7.854,10032,185475,434Feb 23 05:58 PM
Valliant JohnChief Executive OfficerFeb 18Sale7.884,89838,596479,534Feb 23 05:58 PM
Valliant JohnChief Executive OfficerFeb 17Sale7.981,70013,566484,432Feb 17 05:39 PM
Valliant JohnChief Executive OfficerFeb 16Sale7.9933,202265,284486,132Feb 17 05:39 PM
Valliant JohnChief Executive OfficerFeb 15Sale8.3312,600104,958519,334Feb 17 05:39 PM
GANNON STEVENDirectorAug 23Buy7.992,82922,59012,000Aug 23 06:28 PM
GANNON STEVENDirectorAug 19Buy8.053,00024,1509,171Aug 20 04:10 PM
GANNON STEVENDirectorAug 18Buy8.051711,3776,171Aug 20 04:10 PM